Had a fantastic time at Future Labs Live in Basel this year! 🌿 Presented alongside Michael Bösch, Head of Global Sustainability at Roche, Matt Shaughnessy, Head of Operations Sustainability, and moderated by Fiona Adshead, Chair of the Sustainable Healthcare Coalition. Labs play a crucial role in life science innovation, serving as a leverage point for change and transformation and My Green Lab Certification is a crucial tool for turning commitment into action.
Also heard some great talks from friends and supporters including Emelia DeForce who leads green labs and products at Genentech, while Lena T. did a fantastic time representing My Green Lab and Impact Laboratories at our booth.
It's time to scale our impact beyond organizational walls by engaging both suppliers and customers. Let's "raise the bar" to ensure sustainability claims are credible and meaningful.
Big thanks to Future Labs Live Basel and Ellie Whitehead for hosting such a great event annually. 🙌 #greenlabs#sustainability#futurelabs
It was great to catch up with you and Lena, and am very chuffed that the topic of green labs was so well received at FLL this year! Looking forward to leveraging our partnership further in the coming months
Delighted to spotlight the impactful presentation by Adrian Feyhl, Project Manager, and Moritz Edlfurtner, Advanced Expert in Smart & Sustainable Assets at Roche Diagnostics GmbH, during the 2nd Net Zero Life Science Forum. Their session delved into the essential theme: "Navigating the Road to Carbon Footprint Reduction."
Here's a condensed overview of their insightful roadmap:
🌐 Enhancing Transparency in Processes:
Adrian and Moritz emphasized the pivotal role of transparency in processes, emissions, consumer engagement, and engineering. Establishing transparency forms the cornerstone for crafting effective strategies to reduce the carbon footprint.
⚡ Transitioning to Green Energy Sources:
The roadmap outlined a strategic shift towards green energy sources, stressing the need to move towards sources with lower environmental impact. The inclusion of self-generation introduces a dynamic element to the pursuit of sustainability.
🔄 Optimizing Site, Plant, and Processes:
Adrian and Moritz highlighted the critical importance of optimization at every level—site, plant, and process. This holistic optimization approach ensures a comprehensive reduction in the carbon footprint across all operational dimensions.
#NetZeroLSF#CarbonFootprintReduction#SustainabilityRoadmap#RocheDiagnosticsGmbH#FutureBridgeNetZero
We're now on the home straight for next month's Medtech Sustainability Forum event to be held in Boston. 16th May will see medical industry stakeholders, key opinion leaders, academics and researchers, subject experts and standards professionals/regulators discuss what sustainability in healthcare is, why it's important and what to do about it.
Medical colleagues based in N. America with an interest in sustainability should ask if this event could be the right place for them to start deciding how to respond to this major global challenge.
https://lnkd.in/dPKN9aUn
We believe that #partnering is what science needs to advance medicines that matter towards and for actual patient impact. Reasons are multifold ... ensuring diversity of thought, bringing together ideas and approaches, making best use of capital investments and technology platforms, etc. In short, I am really looking forward to BioEurope 2023 and this particular discussion featured by JNJ and Evotec.
#researchneverstops
That’s a wrap: Day 1 of Innovate UK’s Materials Research Exchange (MRE 2024)
Today, our flagship materials innovation event, now in its 10th year, has welcomed researchers, business leaders, investors and stakeholders from the world of materials science to come together to address key challenges and explore the exciting new opportunities emerging from the sector.
Earlier in the day, we heard from Dr Lisa Hazelden, CPO of Innovate UK, who spoke about the need to “turn the plans of today into the innovative products of tomorrow” and said how investing in and developing critical technologies “will help make our society healthier, get our country to net zero and create our digital future.”
Mike Biddle, Innovate UK’s Executive Director for Net Zero outlined Innovate UK’s vision for the UK to prosper from being the fastest transitioning economy to net zero. He spoke of the need to inspire and bring together businesses across supply chains and invest in the best ideas whilst making use of our human and natural capital.
Other highlights of the show:
👉 Inspiring keynote addresses from Jane Nicholson, Executive Director, Research Base, Engineering and Physical Sciences Research Council (EPSRC) Prof David Knowles FREng, CEO, Henry Royce Institute, Dr Cathryn Hickey, CEO, AMRICC, Dr Lucy Smith, Head of Transformation, Materials Processing Institute and Prof Jan-Theodoor Janssen, FREng, Chief Scientist, National Physical Laboratory (NPL).
👉 Four exciting events, alongside the main Advanced Materials Conference, under one roof: Circular Critical Materials Conference, Reimagining Materials and Manufacturing Showcase, Global Research and Innovation in Plastics Sustainability (GRIPS) Conference and Investor Showcase.
👉 40+ exhibitors and fantastic networking opportunities with 2,000 delegates registered
Join us for day 2 with more inspiring talks and opportunities to connect. The Investor Showcase will be spotlighting materials innovators from cutting-edge pre-spinout ventures from UK universities in the morning, followed by established companies in the afternoon.
If you’ve enjoyed the day, why not share it on social media using the hashtag #MRE2024.
Explore the full programme: https://ow.ly/TKIU50RmnVi
View out Materials and Manufacturing Vision 2050 and more: https://ow.ly/6UyL50RmnVh
"Deep Biotech: Disruptive innovation for global sustainability" 👇
An interesting recent report from the BioIndustry Association (BIA) marks a pivotal moment in the UK's science superpower ambitions.
"Deep Biotech: Disruptive innovation for global sustainability" 👇
This comprehensive report not only reveals Deep Biotech's transformative potential but also establishes the BIA as the foremost voice for innovative companies in this field.
"This report is a call to action," declares Steve Bates OBE, CEO of the BIA, inviting policymakers, investors, and the public to join in harnessing the immense power of Deep Biotech for a more sustainable, healthier future.
Read the full report 👉 deepbiotech.org#DeepBiotech#BioIndustryAssociation#Sustainability#Bioeconomy#Innovationhttps://lnkd.in/ekfzNNgC
Happy Innovation Day!
Today we celebrate the imperative role laboratories play as incubators of change, particularly in integrating sustainability into their foundational mission. 🌱 These innovation centers have two main roles: creating solutions for global problems and leading the way in green innovation. Using advanced technology together with eco-friendly practices is now necessary to protect our future.
Learn how Agilent is on the quest for sustainable innovation in our latest article, written in collaboration with Labcompare: 🔗 https://lnkd.in/eFqni-es#innovationday
Entrepreneur / Executive and C-suite consultant / Passionate on people development via knowledge sharing and innovation / Never say "Impossible" but rather "not yet"
The life sciences industry holds a crucial role in improving global health, with research and technological advancements contributing to disease prevention, diagnosis, and treatment. The industry's impact extends beyond individual health, influencing economic development and global health security.
The Covid-19 pandemic prompted rapid adaptations in the life sciences sector, reinforcing supply chains and fostering scientific and regulatory collaborations. While disruptions occurred in non-Covid clinical trials, it accelerated global efforts to strengthen public health systems and optimize healthcare resources.
With ambitious environmental goals set globally, the life sciences industry has a significant role in achieving net-zero carbon by 2050. Healthcare systems contribute 4.4% of global greenhouse gas emissions, making the life sciences industry more climate-negative than aviation or shipping.
Emissions are categorized into three scopes: Scope 1 covers direct emissions from healthcare activities; Scope 2 includes indirect emissions from purchased energy, and Scope 3 comprises all remaining indirect emissions from the supply chain. Energy, mainly from fossil fuels, constitutes over half of the industry's climate footprint across all scopes.
Top pharmaceutical companies are making progress in reducing emissions, with Scope 1 and 2 showing positive trends. However, Scope 3, representing supply chain emissions, poses challenges, and there's a data deficiency in reporting historical commitments.
Investments in efficient and eco-friendly technologies, waste reduction, and recycling contribute to sustainability. Collaboration with suppliers committed to sustainability and the 5-R-rule (refuse, reduce, reuse, repurpose, and recycle) is crucial. Transitioning to cloud-based solutions aids dematerialization, reducing resource consumption.
In summary, a harmonized approach incorporating green initiatives, sustainable practices, and collaboration across the entire life sciences supply chain is crucial for reducing environmental impact and achieving net-zero emissions. The industry's commitment to sustainability will benefit patients, organizations, and the planet.
Read more in Matteo Cadenazzi's latest article on our website: "Shaping the Life Sciences Industry of the Future: Sustainability as a Cornerstone of Societal Progress." 🌍
I am happy to share Matteo Cadenazzi's latest article on our website: "Shaping the Life Sciences Industry of the Future: Sustainability as a Cornerstone of Societal Progress." 🌍
Matteo explores the crucial role of the life sciences industry in global well-being and economic development, especially post-COVID. 🩺✨ The article delves into the industry's swift adaptations during the pandemic, reinforcing supply chains and addressing disruptions in clinical trials.
🌿 Key Focus: Sustainability, the piece emphasizes the industry's potential to lead in environmental sustainability, contributing to the global race for net-zero carbon by 2050. Insights on greenhouse gas emissions reveal opportunities for impactful change in Scopes 1, 2, and 3.
💡 Innovative Strategies: This highlights the importance of comprehensive green initiatives along the entire life sciences supply chain. From R&D improvements to downstream activities, the article discusses strategies for reducing emissions and promoting sustainable practices.
📊 Assessment & Action: Discover the industry's progress in reducing GHG emissions, insights from top global pharmaceutical companies, and the vital role digital tools play in achieving a climate-positive "dematerialization."
🌈 Join the Movement: Explore how the life sciences industry can transform sustainability from compliance into a virtuous circle, benefiting patients, organizations, and the planet. Let's shape a greener future together! 🌱💚
Read the full article here: https://lnkd.in/d9jGjTZE#LifeSciences#Sustainability#Innovation#HealthcareTransformation#NetZero2030#EnvironmentalImpact#ClimateActionINCONCRETO Consulting
Program Manager, Sustainable Science & Product Stewardship
2wSuch a wonderful time! Looking forward to continued collaboration!